NAV: 22 Oct 2024 | ₹20.29 |
Min. SIP amount | Not Supported |
Rating | 2 |
Fund size | ₹162.05Cr |
6M | 1Y | 3Y | All | |
---|---|---|---|---|
Fund returns | NA | 44.1% | 17.6% | 19.7% |
Category average | NA | 52.0% | 19.2% | NA |
Rank with in category | NA | 14 | 9 | NA |
Name | Sector | Instrument | Assets |
---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 13.65% |
Cipla Ltd. | Healthcare | Equity | 6.74% |
Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 6.48% |
Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 5.42% |
Eli Lilly And Co | Healthcare | Forgn. Eq | 5.29% |
Max Healthcare Institute Ltd. | Healthcare | Equity | 5.19% |
Divi's Laboratories Ltd. | Healthcare | Equity | 4.67% |
Lupin Ltd. | Healthcare | Equity | 3.97% |
Aurobindo Pharma Ltd. | Healthcare | Equity | 3.23% |
Novo Nordisk A/S - ADR | Healthcare | Forgn. Eq | 3.05% |
Inclusive of GST
Nil
0.005% (from July 1st, 2020)
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Min. for 1st investment | ₹100 |
Min. for 2nd investment onwards | ₹100 |
Min. for SIP | Not Supported |